 Debashis Ghosh
Concepts (712)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Data Interpretation, Statistical | 27 | 2020 | 332 | 4.920 |
Why?
| | Gene Expression Profiling | 52 | 2023 | 1582 | 4.840 |
Why?
| | Models, Statistical | 42 | 2021 | 633 | 4.350 |
Why?
| | Algorithms | 37 | 2023 | 1516 | 3.960 |
Why?
| | Oligonucleotide Array Sequence Analysis | 35 | 2016 | 761 | 3.350 |
Why?
| | Biomarkers, Tumor | 24 | 2022 | 1047 | 2.580 |
Why?
| | Metabolomics | 9 | 2022 | 540 | 2.530 |
Why?
| | Machine Learning | 8 | 2022 | 320 | 2.440 |
Why?
| | Computer Simulation | 33 | 2023 | 906 | 2.440 |
Why?
| | Biometry | 13 | 2011 | 65 | 2.360 |
Why?
| | Neoplasms | 24 | 2022 | 2144 | 1.970 |
Why?
| | Regression Analysis | 13 | 2021 | 979 | 1.610 |
Why?
| | Genomics | 12 | 2024 | 656 | 1.550 |
Why?
| | Computational Biology | 17 | 2021 | 535 | 1.490 |
Why?
| | Prostatic Neoplasms | 25 | 2012 | 938 | 1.470 |
Why?
| | Neoplasm Proteins | 12 | 2018 | 395 | 1.460 |
Why?
| | Models, Biological | 14 | 2021 | 1695 | 1.430 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 1109 | 1.400 |
Why?
| | Biomarkers | 14 | 2021 | 3540 | 1.350 |
Why?
| | Causality | 4 | 2022 | 109 | 1.270 |
Why?
| | Statistics, Nonparametric | 8 | 2019 | 393 | 1.270 |
Why?
| | Gene Expression Regulation, Neoplastic | 22 | 2021 | 1155 | 1.260 |
Why?
| | Proportional Hazards Models | 10 | 2022 | 1112 | 1.240 |
Why?
| | Software | 13 | 2022 | 561 | 1.200 |
Why?
| | Biostatistics | 3 | 2014 | 18 | 1.180 |
Why?
| | Humans | 164 | 2024 | 116809 | 1.110 |
Why?
| | Meta-Analysis as Topic | 4 | 2014 | 164 | 1.030 |
Why?
| | Microscopy | 3 | 2023 | 123 | 0.990 |
Why?
| | Magnetoencephalography | 2 | 2021 | 103 | 0.980 |
Why?
| | Colonic Neoplasms | 2 | 2022 | 222 | 0.950 |
Why?
| | Histological Techniques | 1 | 2023 | 43 | 0.910 |
Why?
| | Survival Analysis | 11 | 2017 | 1246 | 0.910 |
Why?
| | Lung Neoplasms | 6 | 2022 | 2202 | 0.900 |
Why?
| | Cognitive Dysfunction | 4 | 2021 | 286 | 0.890 |
Why?
| | Genetic Association Studies | 5 | 2019 | 351 | 0.880 |
Why?
| | Multivariate Analysis | 16 | 2022 | 1458 | 0.860 |
Why?
| | Connectome | 2 | 2021 | 63 | 0.830 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 27 | 0.800 |
Why?
| | Mass Spectrometry | 6 | 2022 | 662 | 0.800 |
Why?
| | Propensity Score | 4 | 2018 | 237 | 0.770 |
Why?
| | Endpoint Determination | 2 | 2011 | 69 | 0.760 |
Why?
| | Brain Mapping | 2 | 2021 | 518 | 0.750 |
Why?
| | Phenotype | 11 | 2023 | 2890 | 0.740 |
Why?
| | Clinical Trials as Topic | 4 | 2022 | 955 | 0.730 |
Why?
| | Risk Assessment | 8 | 2020 | 3016 | 0.710 |
Why?
| | High-Throughput Screening Assays | 2 | 2012 | 123 | 0.710 |
Why?
| | Image Processing, Computer-Assisted | 7 | 2024 | 700 | 0.710 |
Why?
| | Models, Genetic | 10 | 2019 | 588 | 0.700 |
Why?
| | Diagnostic Imaging | 1 | 2022 | 293 | 0.700 |
Why?
| | Learning | 1 | 2023 | 375 | 0.690 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 108 | 0.680 |
Why?
| | Genetic Variation | 4 | 2019 | 902 | 0.680 |
Why?
| | DNA Copy Number Variations | 2 | 2017 | 159 | 0.670 |
Why?
| | Quantitative Trait, Heritable | 2 | 2018 | 119 | 0.660 |
Why?
| | Glioma | 1 | 2022 | 302 | 0.660 |
Why?
| | Databases, Factual | 11 | 2020 | 1180 | 0.660 |
Why?
| | Transcriptome | 2 | 2023 | 751 | 0.650 |
Why?
| | Metabolome | 1 | 2021 | 287 | 0.650 |
Why?
| | Databases, Genetic | 10 | 2021 | 213 | 0.650 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2021 | 1226 | 0.640 |
Why?
| | Cardiovascular Diseases | 5 | 2022 | 1784 | 0.640 |
Why?
| | Logistic Models | 12 | 2020 | 1876 | 0.620 |
Why?
| | Reproducibility of Results | 16 | 2021 | 2825 | 0.600 |
Why?
| | Epidemiologic Methods | 2 | 2007 | 72 | 0.590 |
Why?
| | Immunohistochemistry | 11 | 2022 | 1651 | 0.580 |
Why?
| | Retinol-Binding Proteins | 2 | 2014 | 13 | 0.570 |
Why?
| | Eye Proteins | 3 | 2014 | 74 | 0.560 |
Why?
| | Markov Chains | 7 | 2017 | 118 | 0.540 |
Why?
| | Linear Models | 7 | 2018 | 809 | 0.520 |
Why?
| | Autism Spectrum Disorder | 2 | 2017 | 321 | 0.510 |
Why?
| | Empirical Research | 2 | 2012 | 24 | 0.500 |
Why?
| | Diagnosis, Computer-Assisted | 4 | 2008 | 65 | 0.500 |
Why?
| | Neuroendocrine Tumors | 3 | 2024 | 82 | 0.480 |
Why?
| | Carcinoma, Squamous Cell | 4 | 2017 | 608 | 0.480 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 959 | 0.470 |
Why?
| | Bayes Theorem | 6 | 2012 | 342 | 0.460 |
Why?
| | Protein Tyrosine Phosphatases | 3 | 2019 | 143 | 0.460 |
Why?
| | Genome-Wide Association Study | 7 | 2018 | 1306 | 0.450 |
Why?
| | Bias | 5 | 2022 | 195 | 0.440 |
Why?
| | Disease Progression | 14 | 2021 | 2466 | 0.440 |
Why?
| | Cluster Analysis | 9 | 2023 | 477 | 0.430 |
Why?
| | Treatment Outcome | 7 | 2021 | 9212 | 0.430 |
Why?
| | Tissue Array Analysis | 3 | 2008 | 51 | 0.430 |
Why?
| | Oncogenes | 1 | 2013 | 110 | 0.420 |
Why?
| | Aromatase | 1 | 2012 | 31 | 0.420 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2146 | 0.410 |
Why?
| | Sulfhydryl Compounds | 1 | 2014 | 177 | 0.410 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2012 | 111 | 0.400 |
Why?
| | Male | 59 | 2021 | 56636 | 0.400 |
Why?
| | Genome | 5 | 2017 | 270 | 0.400 |
Why?
| | Alzheimer Disease | 3 | 2015 | 474 | 0.390 |
Why?
| | Cardiac Catheterization | 1 | 2015 | 532 | 0.390 |
Why?
| | Adenocarcinoma | 4 | 2017 | 790 | 0.380 |
Why?
| | Liver Neoplasms | 1 | 2015 | 523 | 0.380 |
Why?
| | Supervised Machine Learning | 2 | 2021 | 11 | 0.370 |
Why?
| | Brain | 3 | 2019 | 2385 | 0.370 |
Why?
| | Polymorphism, Single Nucleotide | 5 | 2019 | 2043 | 0.360 |
Why?
| | Antioxidants | 1 | 2014 | 552 | 0.360 |
Why?
| | Endoplasmic Reticulum | 1 | 2012 | 240 | 0.350 |
Why?
| | Gene Expression | 3 | 2014 | 1468 | 0.350 |
Why?
| | Proteomics | 5 | 2009 | 846 | 0.350 |
Why?
| | Stem Cells | 3 | 2020 | 547 | 0.350 |
Why?
| | Epidemiologic Research Design | 1 | 2009 | 28 | 0.340 |
Why?
| | Nerve Tissue Proteins | 3 | 2020 | 541 | 0.340 |
Why?
| | Gene Dosage | 1 | 2010 | 135 | 0.340 |
Why?
| | Ki-67 Antigen | 2 | 2020 | 106 | 0.340 |
Why?
| | Tumor Microenvironment | 2 | 2022 | 449 | 0.340 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2017 | 134 | 0.330 |
Why?
| | Signal Transduction | 9 | 2023 | 4605 | 0.330 |
Why?
| | Bone Marrow Transplantation | 2 | 2008 | 244 | 0.330 |
Why?
| | Carcinoma | 2 | 2007 | 203 | 0.330 |
Why?
| | Sensitivity and Specificity | 10 | 2015 | 1754 | 0.320 |
Why?
| | Protein Array Analysis | 8 | 2009 | 62 | 0.320 |
Why?
| | Emigration and Immigration | 1 | 2008 | 47 | 0.320 |
Why?
| | Racemases and Epimerases | 5 | 2006 | 11 | 0.320 |
Why?
| | Statistical Distributions | 1 | 2008 | 8 | 0.320 |
Why?
| | Probability | 3 | 2021 | 299 | 0.310 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 275 | 0.310 |
Why?
| | DNA-Binding Proteins | 7 | 2018 | 1340 | 0.310 |
Why?
| | Chromosome Mapping | 6 | 2017 | 499 | 0.310 |
Why?
| | Proteome | 3 | 2007 | 349 | 0.300 |
Why?
| | Research Design | 5 | 2021 | 953 | 0.300 |
Why?
| | Flow Cytometry | 2 | 2022 | 1066 | 0.300 |
Why?
| | Tumor Burden | 1 | 2008 | 272 | 0.290 |
Why?
| | Aged | 27 | 2022 | 19362 | 0.290 |
Why?
| | Pancreas | 2 | 2020 | 277 | 0.290 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2021 | 210 | 0.280 |
Why?
| | Nerve Net | 2 | 2019 | 227 | 0.280 |
Why?
| | Female | 42 | 2022 | 60542 | 0.280 |
Why?
| | Diabetes Mellitus | 5 | 2022 | 927 | 0.280 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2019 | 159 | 0.270 |
Why?
| | Placenta | 1 | 2012 | 629 | 0.270 |
Why?
| | Monte Carlo Method | 4 | 2017 | 146 | 0.270 |
Why?
| | Neoplasm Staging | 6 | 2019 | 1213 | 0.260 |
Why?
| | Middle Aged | 29 | 2022 | 27140 | 0.260 |
Why?
| | Cell Proliferation | 5 | 2021 | 2232 | 0.260 |
Why?
| | Magnetic Resonance Imaging | 5 | 2022 | 3101 | 0.260 |
Why?
| | False Positive Reactions | 4 | 2012 | 113 | 0.260 |
Why?
| | Homeodomain Proteins | 4 | 2020 | 466 | 0.260 |
Why?
| | Cell Nucleus | 2 | 2019 | 574 | 0.250 |
Why?
| | Replication Origin | 1 | 2004 | 15 | 0.250 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2019 | 886 | 0.240 |
Why?
| | Data Curation | 1 | 2024 | 11 | 0.240 |
Why?
| | ROC Curve | 5 | 2020 | 464 | 0.240 |
Why?
| | Crystallography, X-Ray | 3 | 2019 | 414 | 0.240 |
Why?
| | Leukemia | 1 | 2006 | 208 | 0.240 |
Why?
| | Carrier Proteins | 2 | 2007 | 723 | 0.230 |
Why?
| | Histones | 4 | 2020 | 544 | 0.230 |
Why?
| | Risk Factors | 12 | 2022 | 8865 | 0.230 |
Why?
| | Coculture Techniques | 1 | 2004 | 204 | 0.230 |
Why?
| | Lupus Nephritis | 1 | 2023 | 55 | 0.230 |
Why?
| | Statistics as Topic | 2 | 2005 | 301 | 0.230 |
Why?
| | Sample Size | 3 | 2008 | 132 | 0.230 |
Why?
| | Organometallic Compounds | 1 | 2023 | 82 | 0.220 |
Why?
| | Membrane Transport Proteins | 1 | 2004 | 136 | 0.220 |
Why?
| | Staining and Labeling | 1 | 2023 | 142 | 0.220 |
Why?
| | Common Variable Immunodeficiency | 1 | 2023 | 27 | 0.220 |
Why?
| | Carcinogens | 1 | 2003 | 107 | 0.220 |
Why?
| | Breast Neoplasms | 7 | 2014 | 1939 | 0.220 |
Why?
| | Personality | 1 | 2004 | 114 | 0.220 |
Why?
| | Neoplasms, Experimental | 1 | 2003 | 156 | 0.220 |
Why?
| | Neuroimaging | 2 | 2015 | 252 | 0.210 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 93 | 0.210 |
Why?
| | Emphysema | 1 | 2023 | 122 | 0.210 |
Why?
| | Tomography, X-Ray Computed | 2 | 2023 | 2398 | 0.210 |
Why?
| | Promoter Regions, Genetic | 3 | 2009 | 1141 | 0.200 |
Why?
| | Artificial Intelligence | 3 | 2008 | 136 | 0.200 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 440 | 0.200 |
Why?
| | Brain Waves | 1 | 2021 | 21 | 0.200 |
Why?
| | Epilepsies, Partial | 1 | 2021 | 32 | 0.200 |
Why?
| | Head and Neck Neoplasms | 2 | 2017 | 470 | 0.200 |
Why?
| | Autoantibodies | 5 | 2020 | 1329 | 0.200 |
Why?
| | Epilepsy | 2 | 2021 | 292 | 0.200 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 216 | 0.200 |
Why?
| | Anxiety Disorders | 1 | 2004 | 307 | 0.190 |
Why?
| | Receptors, Androgen | 2 | 2021 | 132 | 0.190 |
Why?
| | Drug Resistant Epilepsy | 1 | 2021 | 47 | 0.190 |
Why?
| | Adult | 19 | 2022 | 30930 | 0.190 |
Why?
| | Hyaluronan Receptors | 1 | 2021 | 93 | 0.190 |
Why?
| | Polymorphism, Genetic | 1 | 2004 | 635 | 0.190 |
Why?
| | Genotype | 8 | 2019 | 1853 | 0.190 |
Why?
| | Lymphocytes | 2 | 2023 | 341 | 0.190 |
Why?
| | Pattern Recognition, Automated | 4 | 2009 | 73 | 0.180 |
Why?
| | Tandem Mass Spectrometry | 3 | 2014 | 413 | 0.180 |
Why?
| | Recurrence | 4 | 2010 | 960 | 0.180 |
Why?
| | Case-Control Studies | 7 | 2020 | 3120 | 0.180 |
Why?
| | Precision Medicine | 1 | 2024 | 354 | 0.180 |
Why?
| | Mexican Americans | 3 | 2008 | 99 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 316 | 0.180 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 164 | 0.180 |
Why?
| | Herpes Zoster Vaccine | 1 | 2022 | 159 | 0.180 |
Why?
| | Exome | 2 | 2018 | 209 | 0.180 |
Why?
| | Prognosis | 11 | 2021 | 3384 | 0.180 |
Why?
| | Tretinoin | 1 | 2020 | 115 | 0.170 |
Why?
| | Radiography | 1 | 2022 | 844 | 0.170 |
Why?
| | Pancreatic Neoplasms | 3 | 2019 | 713 | 0.170 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2019 | 44 | 0.170 |
Why?
| | Disease | 1 | 2019 | 87 | 0.170 |
Why?
| | Bone Regeneration | 1 | 2019 | 21 | 0.170 |
Why?
| | Environmental Exposure | 2 | 2017 | 394 | 0.170 |
Why?
| | Functional Neuroimaging | 1 | 2019 | 67 | 0.170 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2405 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2019 | 81 | 0.160 |
Why?
| | Precancerous Conditions | 1 | 2020 | 156 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.160 |
Why?
| | Neoplasms, Second Primary | 1 | 2019 | 93 | 0.160 |
Why?
| | Wilms Tumor | 1 | 2019 | 68 | 0.160 |
Why?
| | Pituitary Gland | 2 | 2009 | 163 | 0.160 |
Why?
| | Genetic Markers | 3 | 2015 | 338 | 0.160 |
Why?
| | Protein Phosphatase 2 | 1 | 2018 | 34 | 0.160 |
Why?
| | Observational Studies as Topic | 1 | 2018 | 88 | 0.160 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 463 | 0.160 |
Why?
| | Herpes Zoster | 1 | 2022 | 332 | 0.160 |
Why?
| | Monocytes | 1 | 2020 | 507 | 0.150 |
Why?
| | RNA, Neoplasm | 1 | 2017 | 76 | 0.150 |
Why?
| | CD24 Antigen | 1 | 2017 | 21 | 0.150 |
Why?
| | Parkinson Disease | 1 | 2021 | 332 | 0.150 |
Why?
| | Genes, Neoplasm | 3 | 2007 | 21 | 0.150 |
Why?
| | Neoplasm Metastasis | 6 | 2019 | 536 | 0.150 |
Why?
| | DNA Methylation | 3 | 2017 | 501 | 0.150 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 90 | 0.150 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 152 | 0.150 |
Why?
| | Hypoglycemic Agents | 2 | 2021 | 1024 | 0.150 |
Why?
| | Transcription, Genetic | 7 | 2013 | 1320 | 0.150 |
Why?
| | Child Health | 1 | 2019 | 136 | 0.150 |
Why?
| | Models, Neurological | 1 | 2019 | 215 | 0.150 |
Why?
| | Clinical Trials, Phase III as Topic | 3 | 2012 | 79 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2018 | 114 | 0.150 |
Why?
| | Epigenomics | 1 | 2017 | 106 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2019 | 219 | 0.150 |
Why?
| | Peptides | 3 | 2007 | 871 | 0.150 |
Why?
| | Induction Chemotherapy | 1 | 2017 | 58 | 0.150 |
Why?
| | Animals | 18 | 2021 | 32702 | 0.150 |
Why?
| | Analysis of Variance | 3 | 2017 | 1248 | 0.150 |
Why?
| | Principal Component Analysis | 1 | 2017 | 179 | 0.140 |
Why?
| | RNA, Messenger | 6 | 2017 | 2627 | 0.140 |
Why?
| | Beryllium | 1 | 2018 | 151 | 0.140 |
Why?
| | Osteogenesis | 1 | 2019 | 192 | 0.140 |
Why?
| | Chromosome Aberrations | 2 | 2007 | 135 | 0.140 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 150 | 0.140 |
Why?
| | Memory, Short-Term | 1 | 2019 | 226 | 0.140 |
Why?
| | Aged, 80 and over | 13 | 2022 | 6478 | 0.140 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2016 | 42 | 0.140 |
Why?
| | Anesthesia Department, Hospital | 1 | 2016 | 1 | 0.140 |
Why?
| | Nurse Anesthetists | 1 | 2016 | 3 | 0.140 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 400 | 0.140 |
Why?
| | Up-Regulation | 2 | 2018 | 834 | 0.140 |
Why?
| | B7-H1 Antigen | 1 | 2018 | 143 | 0.140 |
Why?
| | Anesthesia, Obstetrical | 1 | 2016 | 6 | 0.140 |
Why?
| | Transcription Factors | 6 | 2017 | 1558 | 0.140 |
Why?
| | RNA, Small Interfering | 1 | 2019 | 557 | 0.140 |
Why?
| | Normal Distribution | 2 | 2014 | 24 | 0.140 |
Why?
| | Anus Neoplasms | 1 | 2016 | 24 | 0.140 |
Why?
| | Lymph Nodes | 1 | 2019 | 444 | 0.140 |
Why?
| | Salivary Gland Neoplasms | 1 | 2016 | 32 | 0.140 |
Why?
| | DNA, Complementary | 3 | 2005 | 262 | 0.140 |
Why?
| | Heart Arrest | 1 | 2020 | 286 | 0.140 |
Why?
| | Anesthesiologists | 1 | 2016 | 15 | 0.140 |
Why?
| | Analgesia, Obstetrical | 1 | 2016 | 16 | 0.140 |
Why?
| | ErbB Receptors | 2 | 2012 | 567 | 0.140 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 299 | 0.140 |
Why?
| | Transcriptional Activation | 1 | 2018 | 342 | 0.140 |
Why?
| | Insulin-Secreting Cells | 1 | 2020 | 320 | 0.140 |
Why?
| | Mice | 14 | 2021 | 15289 | 0.140 |
Why?
| | Kaplan-Meier Estimate | 3 | 2017 | 830 | 0.140 |
Why?
| | Air Pollution | 2 | 2017 | 200 | 0.140 |
Why?
| | Cough | 2 | 2007 | 102 | 0.140 |
Why?
| | Atrial Fibrillation | 1 | 2020 | 316 | 0.140 |
Why?
| | Protein Binding | 4 | 2019 | 1950 | 0.140 |
Why?
| | Respiratory Sounds | 2 | 2007 | 117 | 0.140 |
Why?
| | Berylliosis | 1 | 2018 | 183 | 0.140 |
Why?
| | Health Services Research | 1 | 2019 | 377 | 0.140 |
Why?
| | Anal Canal | 1 | 2016 | 81 | 0.140 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 535 | 0.130 |
Why?
| | HIV Infections | 3 | 2022 | 2441 | 0.130 |
Why?
| | Colorectal Neoplasms | 3 | 2012 | 622 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2020 | 546 | 0.130 |
Why?
| | Cancer Survivors | 1 | 2019 | 198 | 0.130 |
Why?
| | Cell Transformation, Neoplastic | 4 | 2007 | 311 | 0.130 |
Why?
| | Blood Glucose | 2 | 2022 | 1915 | 0.130 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 283 | 0.130 |
Why?
| | Tumor Cells, Cultured | 4 | 2021 | 861 | 0.130 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 335 | 0.130 |
Why?
| | Kidney Neoplasms | 1 | 2019 | 333 | 0.130 |
Why?
| | Cell Differentiation | 2 | 2020 | 1732 | 0.130 |
Why?
| | Schizophrenia | 1 | 2019 | 416 | 0.130 |
Why?
| | Nuclear Proteins | 1 | 2019 | 591 | 0.130 |
Why?
| | Hypocreales | 1 | 2014 | 8 | 0.130 |
Why?
| | Executive Function | 1 | 2019 | 385 | 0.130 |
Why?
| | Leishmaniasis, Visceral | 1 | 2014 | 5 | 0.120 |
Why?
| | Risk | 1 | 2017 | 842 | 0.120 |
Why?
| | Cell Line, Tumor | 7 | 2019 | 2808 | 0.120 |
Why?
| | Time Factors | 5 | 2016 | 6248 | 0.120 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2481 | 0.120 |
Why?
| | Survival Rate | 4 | 2019 | 1681 | 0.120 |
Why?
| | Discriminant Analysis | 3 | 2020 | 39 | 0.120 |
Why?
| | Ants | 1 | 2014 | 27 | 0.120 |
Why?
| | Metmyoglobin | 1 | 2014 | 2 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2019 | 501 | 0.120 |
Why?
| | Sulfonic Acids | 1 | 2014 | 13 | 0.120 |
Why?
| | Chromatography, Ion Exchange | 1 | 2014 | 49 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 4 | 2019 | 2232 | 0.120 |
Why?
| | Treatment Failure | 1 | 2015 | 337 | 0.120 |
Why?
| | Benzothiazoles | 1 | 2014 | 33 | 0.120 |
Why?
| | Chromatography, Affinity | 1 | 2014 | 84 | 0.120 |
Why?
| | Chromatography, Gel | 1 | 2014 | 129 | 0.120 |
Why?
| | Free Radical Scavengers | 1 | 2014 | 88 | 0.120 |
Why?
| | Cohort Studies | 8 | 2017 | 5047 | 0.120 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 216 | 0.120 |
Why?
| | Brain Diseases | 1 | 2015 | 128 | 0.110 |
Why?
| | Crystallization | 1 | 2014 | 142 | 0.110 |
Why?
| | Odds Ratio | 3 | 2020 | 988 | 0.110 |
Why?
| | Embryonic Stem Cells | 1 | 2014 | 114 | 0.110 |
Why?
| | Influenza, Human | 1 | 2019 | 551 | 0.110 |
Why?
| | Spectrometry, Fluorescence | 1 | 2014 | 167 | 0.110 |
Why?
| | Trans-Activators | 3 | 2020 | 373 | 0.110 |
Why?
| | Estradiol | 2 | 2014 | 467 | 0.110 |
Why?
| | Electronic Health Records | 1 | 2020 | 802 | 0.110 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2021 | 731 | 0.110 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 991 | 0.110 |
Why?
| | Influenza A Virus, H5N1 Subtype | 1 | 2011 | 5 | 0.100 |
Why?
| | Positron-Emission Tomography | 2 | 2024 | 296 | 0.100 |
Why?
| | Heme | 1 | 2012 | 54 | 0.100 |
Why?
| | Least-Squares Analysis | 2 | 2020 | 72 | 0.100 |
Why?
| | Protein Structure, Tertiary | 2 | 2012 | 819 | 0.100 |
Why?
| | Child | 9 | 2023 | 18804 | 0.100 |
Why?
| | Transcription Factor Pit-1 | 1 | 2011 | 24 | 0.100 |
Why?
| | Otx Transcription Factors | 1 | 2011 | 12 | 0.100 |
Why?
| | RNA, Viral | 1 | 2015 | 565 | 0.100 |
Why?
| | Hypopituitarism | 1 | 2011 | 15 | 0.100 |
Why?
| | Motion | 1 | 2012 | 96 | 0.100 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2017 | 80 | 0.100 |
Why?
| | Brucella suis | 1 | 2011 | 1 | 0.100 |
Why?
| | Brucellosis | 1 | 2011 | 3 | 0.100 |
Why?
| | Retina | 1 | 2014 | 271 | 0.100 |
Why?
| | Lung | 2 | 2023 | 3584 | 0.100 |
Why?
| | Caspase 2 | 1 | 2011 | 14 | 0.100 |
Why?
| | Prostatic Intraepithelial Neoplasia | 2 | 2008 | 12 | 0.100 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2011 | 80 | 0.100 |
Why?
| | Chemoradiotherapy | 3 | 2017 | 199 | 0.100 |
Why?
| | Catalytic Domain | 1 | 2012 | 205 | 0.100 |
Why?
| | MicroRNAs | 1 | 2017 | 628 | 0.100 |
Why?
| | Pharmacogenetics | 1 | 2012 | 149 | 0.100 |
Why?
| | Catalysis | 1 | 2012 | 281 | 0.100 |
Why?
| | Age Factors | 3 | 2020 | 2955 | 0.100 |
Why?
| | Mental Disorders | 1 | 2019 | 914 | 0.100 |
Why?
| | Neoplasm Invasiveness | 4 | 2017 | 454 | 0.100 |
Why?
| | Pediatrics | 1 | 2019 | 972 | 0.100 |
Why?
| | Lipid Bilayers | 1 | 2012 | 98 | 0.100 |
Why?
| | Cattle | 1 | 2014 | 955 | 0.100 |
Why?
| | Vaccination | 1 | 2019 | 1217 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2019 | 754 | 0.100 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 906 | 0.100 |
Why?
| | Chemokines | 1 | 2011 | 219 | 0.090 |
Why?
| | Zalcitabine | 1 | 2010 | 2 | 0.090 |
Why?
| | Prevalence | 2 | 2015 | 2301 | 0.090 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2011 | 141 | 0.090 |
Why?
| | Activities of Daily Living | 2 | 2003 | 351 | 0.090 |
Why?
| | Didanosine | 1 | 2010 | 13 | 0.090 |
Why?
| | Gene Silencing | 2 | 2007 | 176 | 0.090 |
Why?
| | Nonlinear Dynamics | 1 | 2010 | 94 | 0.090 |
Why?
| | Phosphoglycerate Kinase | 1 | 2009 | 2 | 0.090 |
Why?
| | Pregnancy | 4 | 2017 | 5650 | 0.090 |
Why?
| | Antibody Formation | 2 | 2007 | 275 | 0.090 |
Why?
| | Sarcosine | 1 | 2009 | 8 | 0.090 |
Why?
| | Decision Trees | 2 | 2020 | 82 | 0.090 |
Why?
| | Delivery of Health Care | 1 | 2016 | 850 | 0.080 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2010 | 113 | 0.080 |
Why?
| | Retinitis Pigmentosa | 1 | 2008 | 18 | 0.080 |
Why?
| | Protein Conformation | 1 | 2012 | 831 | 0.080 |
Why?
| | Anti-HIV Agents | 1 | 2015 | 661 | 0.080 |
Why?
| | Peptide Library | 2 | 2007 | 82 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4516 | 0.080 |
Why?
| | Androgens | 2 | 2009 | 167 | 0.080 |
Why?
| | Genes, Recessive | 1 | 2008 | 73 | 0.080 |
Why?
| | Psoriasis | 1 | 2009 | 76 | 0.080 |
Why?
| | Homozygote | 1 | 2008 | 188 | 0.080 |
Why?
| | Acculturation | 1 | 2008 | 51 | 0.080 |
Why?
| | Exercise | 1 | 2018 | 1613 | 0.080 |
Why?
| | Complex Mixtures | 1 | 2007 | 13 | 0.080 |
Why?
| | Uncertainty | 1 | 2008 | 99 | 0.080 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2007 | 43 | 0.080 |
Why?
| | Respiratory Tract Infections | 1 | 2011 | 329 | 0.080 |
Why?
| | Pituitary Neoplasms | 1 | 2009 | 164 | 0.080 |
Why?
| | Blindness | 1 | 2008 | 35 | 0.080 |
Why?
| | Glaucoma | 1 | 2010 | 202 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2016 | 1186 | 0.080 |
Why?
| | Mice, Nude | 2 | 2021 | 651 | 0.080 |
Why?
| | Confidence Intervals | 1 | 2008 | 316 | 0.080 |
Why?
| | Proteins | 2 | 2003 | 930 | 0.080 |
Why?
| | Socioeconomic Factors | 2 | 2008 | 1113 | 0.070 |
Why?
| | Leisure Activities | 1 | 2007 | 25 | 0.070 |
Why?
| | Lymphatic Metastasis | 2 | 2019 | 305 | 0.070 |
Why?
| | Young Adult | 6 | 2020 | 10643 | 0.070 |
Why?
| | Antibodies, Neoplasm | 1 | 2007 | 30 | 0.070 |
Why?
| | Self Concept | 1 | 2009 | 212 | 0.070 |
Why?
| | Genes, myc | 1 | 2007 | 46 | 0.070 |
Why?
| | Decision Theory | 1 | 2006 | 1 | 0.070 |
Why?
| | Nails | 1 | 2007 | 10 | 0.070 |
Why?
| | Genome, Bacterial | 2 | 2006 | 109 | 0.070 |
Why?
| | Genome, Human | 4 | 2016 | 374 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2007 | 111 | 0.070 |
Why?
| | Mutation, Missense | 1 | 2008 | 299 | 0.070 |
Why?
| | Arsenic | 1 | 2007 | 39 | 0.070 |
Why?
| | Haemophilus Infections | 1 | 2006 | 29 | 0.070 |
Why?
| | Haemophilus influenzae | 1 | 2006 | 49 | 0.070 |
Why?
| | Serine Endopeptidases | 1 | 2007 | 104 | 0.070 |
Why?
| | United States | 7 | 2018 | 12337 | 0.070 |
Why?
| | Pharynx | 1 | 2006 | 52 | 0.070 |
Why?
| | Genes, MHC Class II | 1 | 2006 | 72 | 0.070 |
Why?
| | DNA, Bacterial | 2 | 2006 | 311 | 0.070 |
Why?
| | Death Certificates | 1 | 2006 | 28 | 0.070 |
Why?
| | Diabetic Retinopathy | 1 | 2008 | 151 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2007 | 565 | 0.070 |
Why?
| | Calibration | 2 | 2022 | 133 | 0.070 |
Why?
| | GATA3 Transcription Factor | 1 | 2005 | 26 | 0.070 |
Why?
| | Quantitative Trait Loci | 1 | 2008 | 323 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2023 | 693 | 0.070 |
Why?
| | Lipids | 1 | 2009 | 584 | 0.070 |
Why?
| | Apoptosis | 3 | 2021 | 2427 | 0.070 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2005 | 61 | 0.060 |
Why?
| | Environmental Pollutants | 1 | 2007 | 110 | 0.060 |
Why?
| | Estrogens | 1 | 2008 | 325 | 0.060 |
Why?
| | Body Mass Index | 2 | 2016 | 2058 | 0.060 |
Why?
| | Disease-Free Survival | 3 | 2017 | 643 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2006 | 352 | 0.060 |
Why?
| | Carcinoma, Intraductal, Noninfiltrating | 1 | 2005 | 57 | 0.060 |
Why?
| | Protein Interaction Mapping | 1 | 2005 | 104 | 0.060 |
Why?
| | Area Under Curve | 2 | 2020 | 290 | 0.060 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2004 | 11 | 0.060 |
Why?
| | Environmental Monitoring | 1 | 2007 | 295 | 0.060 |
Why?
| | Poisson Distribution | 1 | 2004 | 68 | 0.060 |
Why?
| | Repressor Proteins | 1 | 2007 | 377 | 0.060 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2004 | 17 | 0.060 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 269 | 0.060 |
Why?
| | Sputum | 1 | 2006 | 290 | 0.060 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2004 | 59 | 0.060 |
Why?
| | Culture Techniques | 1 | 2004 | 81 | 0.060 |
Why?
| | Otitis Media | 1 | 2006 | 142 | 0.060 |
Why?
| | Bacterial Typing Techniques | 1 | 2004 | 41 | 0.060 |
Why?
| | Genetic Heterogeneity | 1 | 2004 | 55 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 2 | 2020 | 400 | 0.060 |
Why?
| | Pedigree | 2 | 2019 | 475 | 0.060 |
Why?
| | Immunophenotyping | 2 | 2020 | 275 | 0.060 |
Why?
| | Macrophages | 1 | 2011 | 1296 | 0.060 |
Why?
| | Gallium Radioisotopes | 1 | 2023 | 19 | 0.060 |
Why?
| | Polybrominated Biphenyls | 1 | 2003 | 1 | 0.060 |
Why?
| | Cause of Death | 1 | 2006 | 372 | 0.060 |
Why?
| | Personality Inventory | 1 | 2004 | 133 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 73 | 0.060 |
Why?
| | Genetics, Population | 1 | 2005 | 206 | 0.060 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 806 | 0.060 |
Why?
| | Expressed Sequence Tags | 1 | 2003 | 38 | 0.060 |
Why?
| | Signal-To-Noise Ratio | 1 | 2023 | 58 | 0.060 |
Why?
| | Asthma | 2 | 2007 | 2157 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2009 | 741 | 0.060 |
Why?
| | Wnt Proteins | 2 | 2020 | 140 | 0.060 |
Why?
| | Bile Ducts | 1 | 2003 | 68 | 0.060 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2019 | 447 | 0.060 |
Why?
| | Hyperplasia | 1 | 2003 | 166 | 0.060 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 103 | 0.060 |
Why?
| | Breast | 1 | 2003 | 136 | 0.060 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2023 | 130 | 0.050 |
Why?
| | Artifacts | 1 | 2023 | 124 | 0.050 |
Why?
| | Colorado | 2 | 2024 | 4118 | 0.050 |
Why?
| | Sarcoma, Ewing | 1 | 2003 | 64 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2023 | 101 | 0.050 |
Why?
| | Biguanides | 1 | 2022 | 12 | 0.050 |
Why?
| | Selection Bias | 1 | 2022 | 34 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2003 | 84 | 0.050 |
Why?
| | Calcium Signaling | 1 | 2004 | 217 | 0.050 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 135 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2008 | 1040 | 0.050 |
Why?
| | Motor Activity | 1 | 2007 | 650 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2008 | 940 | 0.050 |
Why?
| | Biomedical Research | 1 | 2008 | 599 | 0.050 |
Why?
| | Child, Preschool | 3 | 2022 | 9289 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 171 | 0.050 |
Why?
| | Genes, BRCA2 | 1 | 2002 | 25 | 0.050 |
Why?
| | Genes, BRCA1 | 1 | 2002 | 31 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 125 | 0.050 |
Why?
| | Adolescent | 5 | 2020 | 18154 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1185 | 0.050 |
Why?
| | Entropy | 1 | 2021 | 35 | 0.050 |
Why?
| | Genetic Testing | 1 | 2004 | 384 | 0.050 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 392 | 0.050 |
Why?
| | Milk, Human | 1 | 2022 | 134 | 0.050 |
Why?
| | Evolution, Molecular | 1 | 2005 | 449 | 0.050 |
Why?
| | Citrullination | 1 | 2020 | 12 | 0.050 |
Why?
| | Health Care Surveys | 2 | 2016 | 537 | 0.050 |
Why?
| | Interleukin-2 | 1 | 2022 | 416 | 0.050 |
Why?
| | Somatostatin-Secreting Cells | 1 | 2020 | 3 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 963 | 0.050 |
Why?
| | Phosphorylation | 2 | 2018 | 1591 | 0.050 |
Why?
| | Human Embryonic Stem Cells | 1 | 2020 | 19 | 0.050 |
Why?
| | Citalopram | 1 | 2020 | 27 | 0.050 |
Why?
| | Somatostatin | 1 | 2020 | 53 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 503 | 0.050 |
Why?
| | Receptors, Retinoic Acid | 1 | 2020 | 40 | 0.050 |
Why?
| | Quality of Life | 2 | 2009 | 2353 | 0.050 |
Why?
| | Immunity, Cellular | 1 | 2022 | 267 | 0.050 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2022 | 503 | 0.050 |
Why?
| | Policy | 1 | 2021 | 134 | 0.050 |
Why?
| | Support Vector Machine | 1 | 2020 | 36 | 0.040 |
Why?
| | Nutrition Surveys | 1 | 2021 | 231 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 370 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2020 | 218 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 293 | 0.040 |
Why?
| | International Classification of Diseases | 1 | 2020 | 119 | 0.040 |
Why?
| | Allosteric Regulation | 1 | 2019 | 84 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| | Breast Feeding | 1 | 2022 | 381 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2023 | 634 | 0.040 |
Why?
| | Polymethyl Methacrylate | 1 | 2019 | 20 | 0.040 |
Why?
| | Cognition Disorders | 1 | 2003 | 494 | 0.040 |
Why?
| | Binding Sites | 2 | 2017 | 1203 | 0.040 |
Why?
| | Schizophrenic Psychology | 1 | 2019 | 86 | 0.040 |
Why?
| | Epigenesis, Genetic | 2 | 2017 | 534 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2020 | 327 | 0.040 |
Why?
| | SEER Program | 1 | 2019 | 206 | 0.040 |
Why?
| | Seizures | 1 | 2021 | 347 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2022 | 732 | 0.040 |
Why?
| | B-Lymphocytes | 1 | 2023 | 767 | 0.040 |
Why?
| | Virulence | 2 | 2011 | 237 | 0.040 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 219 | 0.040 |
Why?
| | Herpesvirus 3, Human | 1 | 2022 | 381 | 0.040 |
Why?
| | Protein Domains | 1 | 2019 | 212 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2021 | 4488 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 330 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2020 | 2647 | 0.040 |
Why?
| | Prostatic Hyperplasia | 2 | 2008 | 38 | 0.040 |
Why?
| | Adjuvants, Immunologic | 1 | 2019 | 206 | 0.040 |
Why?
| | Autoantigens | 1 | 2020 | 397 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2020 | 488 | 0.040 |
Why?
| | Protein Stability | 1 | 2018 | 163 | 0.040 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2017 | 41 | 0.040 |
Why?
| | Databases, Protein | 2 | 2007 | 59 | 0.040 |
Why?
| | Taiwan | 2 | 2007 | 15 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 569 | 0.040 |
Why?
| | Melanoma | 1 | 2003 | 665 | 0.040 |
Why?
| | Tissue Scaffolds | 1 | 2019 | 184 | 0.040 |
Why?
| | Michigan | 2 | 2007 | 95 | 0.040 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2016 | 10 | 0.040 |
Why?
| | Sterilization, Tubal | 1 | 2016 | 10 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2020 | 12740 | 0.040 |
Why?
| | After-Hours Care | 1 | 2016 | 16 | 0.040 |
Why?
| | Survivors | 1 | 2019 | 408 | 0.030 |
Why?
| | Platelet Count | 1 | 2016 | 81 | 0.030 |
Why?
| | Live Birth | 1 | 2016 | 47 | 0.030 |
Why?
| | Radiotherapy, Intensity-Modulated | 1 | 2017 | 128 | 0.030 |
Why?
| | Prostate | 2 | 2008 | 159 | 0.030 |
Why?
| | Family | 1 | 2019 | 569 | 0.030 |
Why?
| | Cognition | 1 | 2003 | 997 | 0.030 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 2 | 2007 | 39 | 0.030 |
Why?
| | Prostate-Specific Antigen | 2 | 2008 | 154 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2016 | 80 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2017 | 357 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 778 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2019 | 537 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 626 | 0.030 |
Why?
| | Gene Regulatory Networks | 2 | 2007 | 238 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2016 | 196 | 0.030 |
Why?
| | Particulate Matter | 1 | 2017 | 235 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2018 | 274 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2011 | 997 | 0.030 |
Why?
| | Genes, Bacterial | 2 | 2006 | 159 | 0.030 |
Why?
| | Rats | 1 | 2003 | 5177 | 0.030 |
Why?
| | Cell Movement | 1 | 2019 | 879 | 0.030 |
Why?
| | Polycomb Repressive Complex 2 | 2 | 2007 | 61 | 0.030 |
Why?
| | Cesarean Section | 1 | 2016 | 165 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 954 | 0.030 |
Why?
| | Bangladesh | 1 | 2014 | 36 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2015 | 72 | 0.030 |
Why?
| | Cardiovascular System | 1 | 2016 | 127 | 0.030 |
Why?
| | Genes, Essential | 1 | 2014 | 22 | 0.030 |
Why?
| | GATA1 Transcription Factor | 1 | 2014 | 13 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1408 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2014 | 84 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1386 | 0.030 |
Why?
| | CpG Islands | 1 | 2014 | 119 | 0.030 |
Why?
| | Data Collection | 2 | 2007 | 646 | 0.030 |
Why?
| | Receptors, Estrogen | 2 | 2007 | 381 | 0.030 |
Why?
| | North America | 1 | 2014 | 264 | 0.030 |
Why?
| | Methylation | 1 | 2014 | 204 | 0.030 |
Why?
| | Organ Specificity | 1 | 2014 | 270 | 0.030 |
Why?
| | Schizosaccharomyces | 1 | 2013 | 54 | 0.030 |
Why?
| | Host-Parasite Interactions | 1 | 2014 | 109 | 0.030 |
Why?
| | Species Specificity | 1 | 2014 | 557 | 0.030 |
Why?
| | Gene-Environment Interaction | 1 | 2014 | 196 | 0.030 |
Why?
| | Cell Line | 2 | 2009 | 2669 | 0.030 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2013 | 83 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1334 | 0.030 |
Why?
| | Cytokines | 1 | 2020 | 1855 | 0.030 |
Why?
| | Sequence Analysis, DNA | 2 | 2006 | 739 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2012 | 34 | 0.030 |
Why?
| | Carboplatin | 1 | 2012 | 140 | 0.030 |
Why?
| | Cetuximab | 1 | 2012 | 99 | 0.030 |
Why?
| | Prospective Studies | 3 | 2009 | 6371 | 0.030 |
Why?
| | Hospitalization | 1 | 2020 | 1759 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 192 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2011 | 301 | 0.020 |
Why?
| | Mass Screening | 1 | 2018 | 1035 | 0.020 |
Why?
| | Depression | 1 | 2019 | 1130 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 4830 | 0.020 |
Why?
| | Quinazolines | 1 | 2012 | 245 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2125 | 0.020 |
Why?
| | Electrophoresis | 1 | 2009 | 26 | 0.020 |
Why?
| | Pituitary Hormones | 1 | 2009 | 16 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 332 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1370 | 0.020 |
Why?
| | Sarcosine Dehydrogenase | 1 | 2009 | 1 | 0.020 |
Why?
| | Glycine N-Methyltransferase | 1 | 2009 | 3 | 0.020 |
Why?
| | Bone Morphogenetic Protein Receptors, Type I | 1 | 2009 | 10 | 0.020 |
Why?
| | Infant | 1 | 2022 | 8119 | 0.020 |
Why?
| | Blood Pressure | 1 | 2016 | 1633 | 0.020 |
Why?
| | Ophthalmoscopy | 1 | 2008 | 29 | 0.020 |
Why?
| | Electroretinography | 1 | 2008 | 40 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 49 | 0.020 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2011 | 283 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 368 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 274 | 0.020 |
Why?
| | Antineoplastic Agents | 2 | 2012 | 1946 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 124 | 0.020 |
Why?
| | Golgi Apparatus | 1 | 2008 | 91 | 0.020 |
Why?
| | Registries | 1 | 2016 | 1774 | 0.020 |
Why?
| | Chemical Fractionation | 1 | 2007 | 28 | 0.020 |
Why?
| | Genes | 1 | 2008 | 222 | 0.020 |
Why?
| | Chromosomes, Human, 16-18 | 1 | 2007 | 3 | 0.020 |
Why?
| | Chromosomes, Human, 6-12 and X | 1 | 2007 | 3 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 309 | 0.020 |
Why?
| | Tomography, Optical Coherence | 1 | 2008 | 125 | 0.020 |
Why?
| | Keratinocytes | 1 | 2009 | 227 | 0.020 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2012 | 664 | 0.020 |
Why?
| | Chromosomes, Human, Pair 5 | 1 | 2007 | 26 | 0.020 |
Why?
| | Polycomb-Group Proteins | 1 | 2007 | 36 | 0.020 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2007 | 50 | 0.020 |
Why?
| | Feedback | 1 | 2008 | 153 | 0.020 |
Why?
| | DNA Primers | 1 | 2008 | 526 | 0.020 |
Why?
| | Bacteriophage T7 | 1 | 2007 | 3 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2009 | 347 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4634 | 0.020 |
Why?
| | Seaweed | 1 | 2007 | 2 | 0.020 |
Why?
| | Agaricales | 1 | 2007 | 3 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 1151 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 2007 | 242 | 0.020 |
Why?
| | Models, Animal | 1 | 2009 | 347 | 0.020 |
Why?
| | Data Display | 1 | 2007 | 21 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 178 | 0.020 |
Why?
| | Seafood | 1 | 2007 | 16 | 0.020 |
Why?
| | Subtraction Technique | 1 | 2007 | 27 | 0.020 |
Why?
| | Oryza | 1 | 2007 | 21 | 0.020 |
Why?
| | Food Contamination | 1 | 2007 | 45 | 0.020 |
Why?
| | Chromosomes, Human | 1 | 2007 | 40 | 0.020 |
Why?
| | Autophagy-Related Proteins | 1 | 2007 | 46 | 0.020 |
Why?
| | Sequence Analysis, Protein | 1 | 2006 | 29 | 0.020 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2013 | 977 | 0.020 |
Why?
| | Television | 1 | 2007 | 70 | 0.020 |
Why?
| | Inhibitory Concentration 50 | 1 | 2006 | 82 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2007 | 200 | 0.020 |
Why?
| | Fishes | 1 | 2007 | 83 | 0.020 |
Why?
| | Water Supply | 1 | 2007 | 71 | 0.020 |
Why?
| | Nucleic Acid Hybridization | 1 | 2006 | 188 | 0.020 |
Why?
| | Managed Care Programs | 1 | 2007 | 135 | 0.020 |
Why?
| | Ear, Middle | 1 | 2006 | 88 | 0.020 |
Why?
| | Urban Health | 1 | 2006 | 77 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2009 | 468 | 0.020 |
Why?
| | Drug Design | 1 | 2007 | 155 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1138 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1263 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1271 | 0.020 |
Why?
| | Fibrocystic Breast Disease | 1 | 2005 | 3 | 0.020 |
Why?
| | Databases as Topic | 1 | 2005 | 65 | 0.020 |
Why?
| | E2F Transcription Factors | 1 | 2005 | 55 | 0.020 |
Why?
| | Base Composition | 1 | 2005 | 75 | 0.020 |
Why?
| | Oligonucleotide Probes | 1 | 2005 | 53 | 0.020 |
Why?
| | DNA Probes | 1 | 2005 | 57 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 335 | 0.020 |
Why?
| | Housing | 1 | 2006 | 118 | 0.020 |
Why?
| | Bone Morphogenetic Protein Receptors | 1 | 2004 | 4 | 0.020 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2004 | 38 | 0.020 |
Why?
| | Autopsy | 1 | 2004 | 87 | 0.020 |
Why?
| | Skin | 1 | 2009 | 655 | 0.020 |
Why?
| | Receptors, Growth Factor | 1 | 2004 | 49 | 0.020 |
Why?
| | Smad Proteins | 1 | 2004 | 39 | 0.020 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2004 | 40 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2005 | 172 | 0.020 |
Why?
| | Random Allocation | 1 | 2005 | 339 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2007 | 392 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2004 | 140 | 0.010 |
Why?
| | Retinal Diseases | 1 | 2004 | 78 | 0.010 |
Why?
| | Receptors, Progesterone | 1 | 2005 | 324 | 0.010 |
Why?
| | Overweight | 1 | 2007 | 481 | 0.010 |
Why?
| | Selection, Genetic | 1 | 2005 | 249 | 0.010 |
Why?
| | Spermine | 1 | 2002 | 27 | 0.010 |
Why?
| | Spermidine | 1 | 2002 | 18 | 0.010 |
Why?
| | Internet | 1 | 2007 | 595 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2002 | 51 | 0.010 |
Why?
| | California | 1 | 2003 | 369 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 175 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 804 | 0.010 |
Why?
| | Cell Cycle | 1 | 2004 | 545 | 0.010 |
Why?
| | Mutation | 1 | 2012 | 3408 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2006 | 2820 | 0.010 |
Why?
| | Biopsy, Needle | 1 | 2002 | 184 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2003 | 486 | 0.010 |
Why?
| | Comorbidity | 1 | 2006 | 1499 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2006 | 760 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 613 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 3626 | 0.010 |
Why?
| | RNA | 1 | 2005 | 827 | 0.010 |
Why?
| | Stroke | 1 | 2003 | 1021 | 0.010 |
Why?
| | Aging | 1 | 2003 | 1657 | 0.010 |
Why?
|
|
Ghosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|